We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lung Cancer: RESULTS FROM THE PHASE III PARAMOUNT TRIAL.
- Authors
Melosky, Barbara
- Abstract
The article discusses the results of the phase III Paramount trial on maintenance pemetrexed (pem) with best supportive care (BSC) against placebo with BSC in the patients with advanced nonsquamous non-small cell lung cancer (NSCLC). It says that pem continuation maintenance therapy reduces the risk of disease progression as compared to placebo. It adds that treatment with pemetrexed after four cycles of platinum doublet has improved the overall survival of the patients.
- Subjects
CANCER treatment; SMALL cell lung cancer; LUNG cancer patients; TREATMENT effectiveness; DISEASE progression; PLATINUM; CLINICAL trials
- Publication
Oncology Exchange, 2012, Vol 11, Issue 3, p22
- ISSN
1705-2394
- Publication type
Article